SCHEMBL4804079

SCHEMBL4804079

c1nc(OC2CCCNC2)c2ccoc2n1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
JAK3 P52333 2/20 0.44
ROCK1 Q13464 8/20 0.43
ROCK2 O75116 4/20 0.43
KCNH2 Q12809 2/20 0.43
IRAK4 Q9NWZ3 1/20 0.41
CHRNB2 P17787 2/20 0.41
CHRNA4 P43681 2/20 0.41
CDC42BPB Q9Y5S2 3/20 0.40
CDC42BPA Q5VT25 1/20 0.39
JAK2 O60674 1/20 0.39
JAK1 P23458 1/20 0.39
CHEK1 O14757 2/20 0.39
DRD1 P21728 1/20 0.37
PRKCI P41743 1/20 0.36
EED O75530 1/20 0.36
PRKX P51817 1/20 0.36
PRKCE Q02156 1/20 0.36
PRKCD Q05655 1/20 0.36
PRKD1 Q15139 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17545945 0.78 JAK3 (0.73) JAK3ROCK1ROCK2KCNH2IRAK4
SCHEMBL15425827 0.73 IRAK4 (0.51) JAK3IRAK4JAK2JAK1DRD1
SCHEMBL16764917 0.71 ROCK1 (0.53) ROCK1ROCK2KCNH2IRAK4CHRNB2
SCHEMBL16764914 0.71 ROCK1 (0.53) ROCK1ROCK2KCNH2IRAK4CHRNB2
SCHEMBL1787658 0.69 CHEK1 (0.42) ROCK1ROCK2KCNH2CHRNB2CHRNA4
SCHEMBL15406002 0.69 IRAK4 (0.61) KCNH2IRAK4JAK2JAK1DRD1
SCHEMBL15406003 0.69 IRAK4 (0.61) KCNH2IRAK4JAK2JAK1DRD1
SCHEMBL16084815 0.68 CHRNB2 (0.48) ROCK1ROCK2KCNH2IRAK4CHRNB2
Formic Acid SCHEMBL15406065 0.68 IRAK4 (0.48) JAK3IRAK4JAK2JAK1DRD1
Formic Acid SCHEMBL15413427 0.68 IRAK4 (0.48) JAK3IRAK4JAK2JAK1DRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008131859-A2 USE OF CYCLICALLY SUBSTITUTED FUROPYRIMIDINE DERIVATIVES FOR TREATING PULMONARY ARTERIAL HYPERTONIA BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2008-11-06 WO disclosed